がん放射線治療について
CyberKnife®︎S7TM
TomoTherapy®︎
Radixact®︎
ソフトウェア
サービス
CyberKnife®︎
TomoTherapy®︎& Radixact®︎
アキュレイ について
ニュース&イベント
カテゴリ
適応(文献情報)
Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas.(2022)
Arteriovenous malformations treated with frameless robotic radiosurgery using non-invasive angiography: long-term outcomes of a single center pilot study.(2020)
The Long-Term Outcome of CyberKnife-Based Stereotactic Radiotherapy for Head and Neck Paragangliomas: A Single-Center Experience.(2021)
Is fractionated robotic stereotactic body radiosurgery optional salvage treatment for the re-irradiation of locally recurrent nasopharyngeal carcinoma?(2022)
Treatment of chordomas and chondrosarcomas with CyberKnife Robotic hypofractionated radiosurgery: a single institution experience.(2021).
Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis.(2023)
High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.(2022)
Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China.(2021)
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy.(2021)
このサイトは、弊社製品に関する情報を医療従事者の皆様に提供することを目的に作成されています。一般の方への情報提供を目的とするものではありませんので、ご了承ください。
※「はい」を記憶させるには、お使いのプラウザのCookie設定を有効にしてください。